38 results Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Digital Law Up(to)date: No processing of vaccination status in recruitment process The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Coronavirus and insurance The coronavirus will impact almost all aspects of the insurance sector and will trigger many insurance policies. It is important to analyse your insurance policy terms and conditions and to determine whether and to what extent you are covered. Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Supreme Court approves criminal liability of suspect refusing to unlock his smartphone In a groundbreaking judgment, the Belgian Supreme Court (Court of Cassation) states that the investigating judge may order a suspect to provide the access code of his mobile phone. Hans Van Bavel and Charlotte Conings shed a light on the judgment. Stibbe advises Abry Partners and KORE Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe represents Swiss Life Stibbe represented Swiss Life before the criminal courts of Antwerp in a case in which it is charged with issuing "Tak 23" investment products that are financed by means of an allegedly illegal system of mortgage loans. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe represents major insurance company Stibbe represented a major insurance company in its defence before the Brussels Court against a group of claimants who purchased life insurance schemes linked to Traded Endowment Funds. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Pagination Current page 1 Page 2 Page 3 Next page
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Digital Law Up(to)date: No processing of vaccination status in recruitment process The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Coronavirus and insurance The coronavirus will impact almost all aspects of the insurance sector and will trigger many insurance policies. It is important to analyse your insurance policy terms and conditions and to determine whether and to what extent you are covered.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
Supreme Court approves criminal liability of suspect refusing to unlock his smartphone In a groundbreaking judgment, the Belgian Supreme Court (Court of Cassation) states that the investigating judge may order a suspect to provide the access code of his mobile phone. Hans Van Bavel and Charlotte Conings shed a light on the judgment.
Stibbe advises Abry Partners and KORE Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe represents Swiss Life Stibbe represented Swiss Life before the criminal courts of Antwerp in a case in which it is charged with issuing "Tak 23" investment products that are financed by means of an allegedly illegal system of mortgage loans.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe represents major insurance company Stibbe represented a major insurance company in its defence before the Brussels Court against a group of claimants who purchased life insurance schemes linked to Traded Endowment Funds.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.